ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.531,88
-0,69%
S&P 500
5.320,85
-0,01%
US Dollar vs BRL
5,1516
0,55%
Bitcoin
69.774,67
-0,51%
Brent Oil
81,755
-0,84%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Athira Pharma Inc (ATHA)

  7. Athira Pharma Inc (ATHA) Notícias

ATHA

Athira Pharma (ATHA)

Athira Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ATHA
DataHoraFonteTítuloCódigoCompanhia
17/05/202418:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
17/05/202418:00GlobeNewswire Inc.Athira Pharma Announces Proposed Settlement of Stockholder Derivative ActionNASDAQ:ATHAAthira Pharma Inc
15/05/202417:05GlobeNewswire Inc.Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
02/05/202408:00GlobeNewswire Inc.Athira Pharma to Participate in Upcoming May ConferencesNASDAQ:ATHAAthira Pharma Inc
15/04/202408:00GlobeNewswire Inc.Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical OfficerNASDAQ:ATHAAthira Pharma Inc
11/04/202408:00GlobeNewswire Inc.Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
03/04/202408:00GlobeNewswire Inc.Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual MeetingNASDAQ:ATHAAthira Pharma Inc
08/03/202409:00GlobeNewswire Inc.Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International ConferenceNASDAQ:ATHAAthira Pharma Inc
22/02/202418:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ATHAAthira Pharma Inc
22/02/202418:05GlobeNewswire Inc.Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
16/02/202419:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
16/02/202418:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
08/02/202418:02GlobeNewswire Inc.Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)NASDAQ:ATHAAthira Pharma Inc
08/01/202409:00GlobeNewswire Inc.Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business UpdateNASDAQ:ATHAAthira Pharma Inc
03/01/202409:00GlobeNewswire Inc.Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
12/12/202309:00GlobeNewswire Inc.Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy BodiesNASDAQ:ATHAAthira Pharma Inc
29/11/202309:00GlobeNewswire Inc.Athira Pharma to Participate in Sidoti December Small Cap Investor ConferenceNASDAQ:ATHAAthira Pharma Inc
28/11/202309:00GlobeNewswire Inc.Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MNDNASDAQ:ATHAAthira Pharma Inc
15/11/202310:15GlobeNewswire Inc.Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
09/11/202318:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHAAthira Pharma Inc
09/11/202318:05GlobeNewswire Inc.Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
08/11/202309:00GlobeNewswire Inc.Athira Pharma to Participate in Jefferies London Healthcare ConferenceNASDAQ:ATHAAthira Pharma Inc
05/10/202317:30GlobeNewswire Inc.Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)NASDAQ:ATHAAthira Pharma Inc
28/09/202308:00GlobeNewswire Inc.Athira Pharma to Participate in Upcoming October ConferencesNASDAQ:ATHAAthira Pharma Inc
19/09/202308:00GlobeNewswire Inc.Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ATHAAthira Pharma Inc
10/08/202317:05GlobeNewswire Inc.Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
17/07/202308:00GlobeNewswire Inc.Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
06/07/202308:00GlobeNewswire Inc.Athira Pharma Announces Upcoming Presentations at the Alzheimer’s Association International Conference (AAIC) 2023NASDAQ:ATHAAthira Pharma Inc
09/06/202318:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATHAAthira Pharma Inc
31/05/202308:00GlobeNewswire Inc.Athira Pharma to Participate in Upcoming June ConferencesNASDAQ:ATHAAthira Pharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ATHA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
HAGA3
HAGA ON
BOV
AMER3
Americanas ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
IRBR3
IRB BRASIL ON
BOV
AZEV4
AZEVEDO PN
BOV
AMAR3
LOJAS MARISA ON
BOV
HBOR3
HELBOR ON
BOV
COGN3
COGNA ON
BOV
BRKM5
BRASKEM PNA
BOV
LUPA3
LUPATECH ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
BEEF3
MINERVA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados